| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Lee Gary K. serves as a Chief Scientific Officer at LYEL. Across recent SEC filings that breaks down to 0 buys and 9 sells. Those positions are worth an estimated $252K at current prices.
Historically, Lee Gary K.'s trades have earned a below-average insider score of 40/100 across 6 rated trades. On a 3-month view, 33.3% of the rated trades came out ahead, averaging -31.4% over three months.
The biggest single holding is LYEL (~$252K) as Chief Scientific Officer. The recent filings there lean toward selling, a net 5,394 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | LYEL Lyell Immunopharma, Inc. | Chief Scientific Officer | Sell | 1,457 | $15.54 | $22,641.78 | -8.2% | - | - | |
| Aug 10, 2026 | LYEL Lyell Immunopharma, Inc. | Chief Scientific Officer | Sell | 131 | $14.34 | $1,878.54 | -0.7% | - | - | |
| May 11, 2026 | LYEL Lyell Immunopharma, Inc. | Chief Scientific Officer | Sell | 130 | $18.92 | $2,459.60 | -0.7% | -25.4% | - | |
| Feb 11, 2026 | LYEL Lyell Immunopharma, Inc. | Chief Scientific Officer | Sell | 1,671 | $23.39 | $39,084.69 | -9.0% | -20.9% | - | |
| Feb 10, 2026 | LYEL Lyell Immunopharma, Inc. | Chief Scientific Officer | Sell | 147 | $23.12 | $3,398.64 | -0.8% | -19.0% | - | |
| Nov 10, 2025 | LYEL Lyell Immunopharma, Inc. | Chief Scientific Officer | Sell | 138 | $16.16 | $2,230.08 | -0.9% | +31.5% | - | |
| Aug 21, 2025 | LYEL Lyell Immunopharma, Inc. | Chief Scientific Officer | Sell | 1,453 | $10.54 | $15,320.43 | -8.6% | +61.7% | +45.8% | |
| Aug 12, 2025 | LYEL Lyell Immunopharma, Inc. | Chief Scientific Officer | Sell | 267 | $10.43 | $2,784.87 | -2.9% | +67.3% | +34.1% |